Literature DB >> 12115882

Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance.

Balázs Döme1, Sándor Paku, Beáta Somlai, József Tímár.   

Abstract

This study was undertaken to determine the role and the fate of the peritumoural vascular plexus during the vascularization of human malignant melanoma (hMM) and in an appropriate murine melanoma model system. The prognostic significance of the vascularity of different tumour areas was also evaluated. Despite morphometry revealing several-fold higher microvessel densities (MVDs) in the peritumoural tissue than at the centre of the tumour, the development of visceral metastases of hMM was exclusively correlated with the MVD of the tumour centre. Furthermore, the 5-year survival of the patient group with low tumour centre MVD (<30/mm(2), n=29) was 100%, compared to 1/16 patients alive with high tumour centre MVD (>30/mm(2), n=16). Morphometric analysis and three-dimensional reconstruction of vessel networks of both human and murine melanomas showed clearly that the peritumoural vascular plexus present at the melanoma base is continuously being incorporated into the growing tumour mass. Once vessels become incorporated, sprouting ceases and the proliferating endothelial cells (EC) take part only in vessel dilatation. Moreover, the immunohistochemical and ultrastructural characterization of microvessels demonstrated that the pericyte coverage of endothelial tubes was complete in all of the investigated areas, in both human and murine melanomas. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12115882     DOI: 10.1002/path.1124

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  49 in total

1.  Physical determinants of vascular network remodeling during tumor growth.

Authors:  M Welter; H Rieger
Journal:  Eur Phys J E Soft Matter       Date:  2010-07-06       Impact factor: 1.890

2.  Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.

Authors:  Christian Marinaccio; Giuseppe Giudice; Eleonora Nacchiero; Fabio Robusto; Giuseppina Opinto; Gaetano Lastilla; Eugenio Maiorano; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2015-08-15       Impact factor: 3.984

Review 3.  Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Authors:  József Tímár; Balázs Gyorffy; Erzsébet Rásó
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

4.  Endothelial progenitor cells in non-small cell lung cancer.

Authors:  B Dome; J Timar; G Ostoros; S Paku
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 5.  Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

Authors:  Balázs Döme; Mary J C Hendrix; Sándor Paku; József Tóvári; József Tímár
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

6.  Flow-correlated dilution of a regular network leads to a percolating network during tumor-induced angiogenesis.

Authors:  R Paul
Journal:  Eur Phys J E Soft Matter       Date:  2009-09-24       Impact factor: 1.890

7.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

8.  Alteration of angiogenic patterns on B16BL6 melanoma development promoted in Matrigel.

Authors:  Shuji Kitahara; Shunichi Morikawa; Kazuhiko Shimizu; Hiroyuki Abe; Taichi Ezaki
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

Review 9.  Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.

Authors:  Chao-Nan Qian
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 10.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.